{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T18:41:13Z","timestamp":1769280073245,"version":"3.49.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"29","license":[{"start":{"date-parts":[[2013,10,4]],"date-time":"2013-10-04T00:00:00Z","timestamp":1380844800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Anal Bioanal Chem"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1007\/s00216-013-7361-8","type":"journal-article","created":{"date-parts":[[2013,10,3]],"date-time":"2013-10-03T04:36:07Z","timestamp":1380774967000},"page":"9455-9466","source":"Crossref","is-referenced-by-count":21,"title":["A novel approach to quantitative LC-MS\/MS: therapeutic drug monitoring of clozapine and norclozapine using isotopic internal calibration"],"prefix":"10.1007","volume":"405","author":[{"given":"Lewis","family":"Couchman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah L.","family":"Belsey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon A.","family":"Handley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Flanagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,10,4]]},"reference":[{"key":"7361_CR1","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/FTD.0b013e3181dad1fb","volume":"32","author":"L Couchman","year":"2010","unstructured":"Couchman L, Morgan PE, Spencer EP, Flanagan RJ (2010) Plasma clozapine, norclozapine, and the clozapine:norclozapine ratio in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service, 1993\u20132007. Ther Drug Monit 32:438\u2013447","journal-title":"Ther Drug Monit"},{"key":"7361_CR2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-0031-1286287","volume":"44","author":"C Hiemke","year":"2011","unstructured":"Hiemke C, Baumann P, Bergemann N, Conca A, Dietmaier O, Egberts K et al (2011) AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update. Pharmacopsychiatry 44:195\u2013235","journal-title":"Pharmacopsychiatry"},{"key":"7361_CR3","unstructured":"FDA\/CDER (Food and Drug Administration\/Center for Drug Evaluation and Research) (2001) Guidance for industry. Bioanalytical method validation. http:\/\/www.fda.gov\/cder\/guidance\/4252fnl.htm . Accessed 10 January 2013"},{"key":"7361_CR4","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.1021\/ac070054s","volume":"79","author":"FT Peters","year":"2007","unstructured":"Peters FT, Maurer HH (2007) Systematic comparison of bias and precision data obtained with multiple-point and one-point calibration in six validated multi-analyte assays for quantification of drugs in human plasma. Anal Chem 79:4967\u20134976","journal-title":"Anal Chem"},{"key":"7361_CR5","unstructured":"Crawford M, Rappold B, Grant RP. Clinical calibration: moving away from the line. https:\/\/www.msacl.org\/2013_Long_Abstracts\/crawfm1labcorp_201210101341_6878583.pdf . Accessed 02 March 2013"},{"key":"7361_CR6","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1093\/clinchem\/30.7.1168","volume":"30","author":"GJ Kemp","year":"1984","unstructured":"Kemp GJ (1984) Theoretical aspects of one-point calibration: causes and effects of some potential errors, and their dependence on concentration. Clin Chem 30:1168\u20131170","journal-title":"Clin Chem"},{"key":"7361_CR7","author":"MT Olson","year":"2013","unstructured":"Olson MT, Breaud A, Harlan R, Emezienna N, Schools S, Yergey AL, Clarke W (2013) Alternative calibration strategies for the clinical laboratory: application to nortriptyline therapeutic drug monitoring. Clin Chem. doi: 10.1373\/clinchem.2012.194639","journal-title":"Clin Chem"},{"key":"7361_CR8","doi-asserted-by":"crossref","unstructured":"Grant RP (2013) The march of the masses. Clin Chem. Doi. 10.1373\/clinchem.2013.205435","DOI":"10.1373\/clinchem.2013.205435"},{"key":"7361_CR9","unstructured":"Cooper DP, Eastwood MP, Roberts M, Molloy BJ. Internal calibration: toward random access LC-MS analysis. https:\/\/www.msacl.org\/2013_Long_Abstracts\/201212010515_27984.pdf . Accessed 02 March 2013"},{"key":"7361_CR10","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/bmc.1130090108","volume":"9","author":"PT McCarthy","year":"1995","unstructured":"McCarthy PT, Hughes S, Paton C (1995) Measurement of clozapine and norclozapine in plasma\/serum by high performance liquid chromatography with ultraviolet detection. Biomed Chromatogr 9:36\u201341","journal-title":"Biomed Chromatogr"},{"key":"7361_CR11","doi-asserted-by":"crossref","unstructured":"Fisher DS, Partridge SJ, Handley SA, Couchman L, Morgan PE, Flanagan RJ (2013) LC-MS\/MS of some atypical antipsychotics in human plasma, serum, oral fluid and haemolysed whole blood. Forensic Sci Int. 229:145\u2013150. doi: 10.1016\/j.forsciint.2013.02.010","DOI":"10.1016\/j.forsciint.2013.02.010"},{"key":"7361_CR12","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/(SICI)1097-0231(19990630)13:12<1175::AID-RCM639>3.0.CO;2-0","volume":"13","author":"R Bonfiglio","year":"1999","unstructured":"Bonfiglio R, King RC, Olah TV, Merkle K (1999) The effects of sample preparation methods on the variability of the electrospray ionization response for model drug compounds. Rapid Commun Mass Spectrom 13:1175\u20131185","journal-title":"Rapid Commun Mass Spectrom"},{"key":"7361_CR13","doi-asserted-by":"crossref","unstructured":"Fisher DS, Partridge SJ, Handley SA, Flanagan RJ (2013) Stability of some atypical antipsychotics in human plasma, haemolysed whole blood, oral fluid, human serum and calf serum. Forensic Sci Int. 229:151\u2013156. doi: 10.1016\/j.forsciint.2013.03.021","DOI":"10.1016\/j.forsciint.2013.03.021"},{"key":"7361_CR14","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0021-9673(94)01116-V","volume":"693","author":"K Croes","year":"1995","unstructured":"Croes K, McCarthy PT, Flanagan RJ (1995) HPLC of basic drugs and quaternary ammonium compounds on microparticulate strong cation-exchange materials using methanolic or aqueous methanol eluents containing an ionic modifier. J Chromatogr A 693:289\u2013306","journal-title":"J Chromatogr A"},{"key":"7361_CR15","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jpba.2009.07.007","volume":"50","author":"E Choong","year":"2009","unstructured":"Choong E, Rudaz S, Kottelat A, Guillarme D, Veuthey JL, Eap CB (2009) Therapeutic drug monitoring of seven psychotropic drugs and four metabolites in human plasma by HPLC-MS. J Pharm Biomed Anal 50:1000\u20131008","journal-title":"J Pharm Biomed Anal"},{"key":"7361_CR16","first-page":"10","volume":"6","author":"PE Morgan","year":"2010","unstructured":"Morgan PE, Couchman L, Robinson S, McDonnell S, Flanagan RJ (2010) Analysis of clozapine and norclozapine in plasma using on-line sample preparation and LC-MS\/MS. LCGC: Column 6:10\u201316","journal-title":"LCGC: Column"},{"key":"7361_CR17","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/bmc.1566","volume":"25","author":"L Couchman","year":"2011","unstructured":"Couchman L, Morgan PE (2011) LC-MS in analytical toxicology: some practical considerations. Biomed Chromatogr 25:100\u2013123","journal-title":"Biomed Chromatogr"},{"key":"7361_CR18","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/bmc.1530","volume":"25","author":"L Couchman","year":"2011","unstructured":"Couchman L, Morgan PE, Flanagan RJ (2011) Basic drug analysis by strong cation-exchange liquid chromatography-tandem mass spectrometry: simultaneous analysis of amisulpride, and of metamfetamine and amfetamine in serum\/plasma. Biomed Chromatogr 25:867\u2013872","journal-title":"Biomed Chromatogr"}],"container-title":["Analytical and Bioanalytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-013-7361-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00216-013-7361-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-013-7361-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T06:47:51Z","timestamp":1596610071000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00216-013-7361-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,4]]},"references-count":18,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["7361"],"URL":"https:\/\/doi.org\/10.1007\/s00216-013-7361-8","relation":{},"ISSN":["1618-2642","1618-2650"],"issn-type":[{"value":"1618-2642","type":"print"},{"value":"1618-2650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,4]]}}}